HHCP
MRK icon

Hilton Head Capital Partners’s Merck MRK Stock Holding History

Hilton Head Capital Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Sell
15,656
-2,534
-14% -$297K 1.01% 23
2026
Q1 		$2.19M Sell
18,190
-28
-0.2% -$3.23K 1.23% 16
2025
Q4 		$1.92M Buy
+18,218
New +$1.71M 1.12% 18

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hilton Head Capital Partners's MRK Position: Q2 2026 in Review

Hilton Head Capital Partners reduced its Merck (MRK) stake by 14% in Q2 2026, selling an estimated $297K and leaving 15,656 shares worth $2.01M. The position accounts for 1.01% of the portfolio, ranked #23.

Hilton Head Capital Partners first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.19M in Q1 2026. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Hilton Head Capital Partners held 15,656 shares of Merck worth $2.01M as of Q2 2026.
  • Hilton Head Capital Partners sold 2,534 Merck shares in Q2 2026, an estimated $297K.
  • Merck made up 1.01% of Hilton Head Capital Partners's portfolio in Q2 2026, its #23 holding.
  • Hilton Head Capital Partners first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • Hilton Head Capital Partners's Merck position peaked at $2.19M in Q1 2026.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Hilton Head Capital Partners's 13F filing for Q2 2026, filed 27 Jul 2026.